GlassScriptPhysician profile
Lindsay Carter
NPI 1629485438
$108,217.28
in general payments reported to CMS, 2019-2025
35 companies · $72K in 2025
The $72K reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,352 · 2022: $6,672 · 2023: $7,381 · 2024: $21K · 2025: $72K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $47K · Food and Beverage: $25K · Travel and Lodging: $23K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $47,196.88 |
| Food and Beverage | $24,561.00 |
| Travel and Lodging | $22,735.96 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,700.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $41,702.53 | 2023-2025 | Evoke, Evoke Scs |
| Nalu Medical, INC. | $40,344.43 | 2023-2025 | Nalu Neurostimulation System |
| Globus Medical, INC. | $8,059.96 | 2025 | Senza |
| Abbott Laboratories | $4,963.50 | 2021-2025 | Eterna, Proclaim |
| Boston Scientific Corporation | $3,883.91 | 2021-2025 | Intracept, General - Pain Management, Bionic Navigator |
| Spinal Simplicity, LLC | $3,289.69 | 2022-2025 | Ha Minuteman G3-R |
| Nevro Corp. | $2,018.73 | 2021-2024 | Senza |
| Vertos Medical, INC. | $964.17 | 2022-2024 | Mild Device Kit |
| Medtronic, INC. | $728.76 | 2022-2024 | Intellis Adaptivestim |
| Spr Therapeutics, INC | $644.16 | 2022-2023 | Sprint Pns System |
| Painteq LLC | $461.96 | 2022 | |
| Abbvie INC. | $163.99 | 2021-2025 | |
| Pacira Therapeutics, INC. | $139.67 | 2021 | |
| Foundation Fusion Solutions, LLC | $137.12 | 2025 | |
| Grt US Holding, INC. | $114.72 | 2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $87.71 | 2025 | Reactiv8 |
| Collegium Pharmaceutical, INC. | $77.46 | 2021-2023 | Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $76.41 | 2021-2025 | Relistor |
| Pacira Pharmaceuticals Incorporated | $42.61 | 2024 | Iovera, Zilretta |
| Averitas Pharma INC. | $32.96 | 2023 | Qutenza |
| Protega Pharmaceutials INC | $29.69 | 2024 | Roxybond |
| Teva Pharmaceuticals USA, INC. | $25.44 | 2022 | |
| Almatica Pharma LLC | $24.16 | 2021 | |
| Valinor Pharma, LLC | $24.11 | 2023 | Movantik |
| Novartis Pharmaceuticals Corporation | $21.06 | 2021 | |
| Lilly USA, LLC | $18.66 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $18.54 | 2021 | |
| Amgen INC. | $17.94 | 2021 | |
| Ferring Pharmaceuticals INC. | $17.23 | 2022 | |
| Scilex Pharmaceuticals INC. | $17.20 | 2021 | |
| Avanos Medical | $15.36 | 2023 | Generator |
| Vertex Pharmaceuticals Incorporated | $14.85 | 2025 | |
| Si-Bone, INC. | $14.09 | 2025 | |
| Biodelivery Sciences International, INC. | $12.50 | 2021 | |
| Redhill Biopharma INC. | $12.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsay Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.